Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

CollabRx and Alacris partner on cancer sequencing project
March 2009
SHARING OPTIONS:

SAN FRANCISCOóCollabRx Inc. has announced the launch of its new personalized cancer research service, CollabRx ONE, designed to provide physicians with new insights into specific treatment options for their cancer patients, using such technologies as gene expression, SNP analysis and copy number variation, to analyze biopsies of an individual patient's tumor. At the same time, the company announced the initiation of the TREAT1000 project, a joint project of CollabRx and Alacris Pharmaceuticals, to sequence the genomes of 1,000 cancer patients and add that data to the CollabRx ONE offering.

Back



PAGE UTILITIES


CONTACT US
DDNEWS
1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.